Solvents Can Inactivate Pt-Based Drugs

  • Author:
  • Published: 29 June 2017
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Dalton Transactions/Royal Society of Chemistry (RSC)
  • Associated Societies: Royal Society of Chemistry (RSC), UK
thumbnail image: Solvents Can Inactivate Pt-Based Drugs

Platinum (II) complexes are commonly used as cancer drugs. Examples for such complexes are cisplatin [Pt(NH3)2Cl2], carboplatin [Pt(NH3)2(CBDCA)], and oxaliplatin [Pt(DACH)(Ox)] (pictured, CBDCA = 1,1-cyclobutanedicarboxylate, DACH = (1R,2R)-1,2-diaminocyclohexane, Ox = oxalate). These drugs are usually studied in aqueous solution, often with added dimethyl sulfoxide (DMSO). However, a decrease in anticancer activity has been observed for Pt complexes in the presence of DMSO.

Paul J. Dyson, Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, Hristo P. Varbanov, EPFL and University of Vienna, Austria, and colleagues have investigated the effects of water and DMSO on oxaliplatin. The team used electrospray ionization mass spectrometry (ESI-MS) and 1H-NMR spectroscopy to monitor the stability of oxaliplatin in pure DMSO, in DMSO/water mixtures, and in pure water.

The team found that oxaliplatin is stable in pure DMSO. However, when water was added to solutions of oxaliplatin in DMSO, the complex reacted rapidly and formed DMSO adducts. According to the researchers, this is caused by DMSO binding to the metal center after water has caused the cleavage of oxalate-Pt bonds. The bound DMSO then prevents the reattachment of the oxalate ligand. In pure water, the same bond cleavage happens, but the reattachment reaction is extremely fast, which causes the complex to be stable overall. The team states that DMSO should be avoided in biological experiments on Pt(II) complexes, since the water in biological systems could affect the results.


Article Views: 1156

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH